P. Hohenberger

Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.

A.S. Lübbe, Christian Bergemann, Hanno Riess et al. · PubMed · 1996 · 653 citations

Magnetic Fluids, Pharmacotherapy, Advanced Solid Tumors +16

First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study

Judith R. Kroep, M. Ouali, Hans Gelderblom et al. · Annals of Oncology · 2010 · 207 citations · Full text

Surgical Oncology, Tumoral Pathology, Tumor Innervation +10

Results of surgery and multimodal therapy for patients with soft tissue sarcoma invading to vascular structures

P. Hohenberger, Jens R. Allenberg, Peter M. Schlag et al. · Cancer · 1999 · 91 citations

Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)☆

Paolo G. Casali, Axel Le Cesne, A. Poveda Velasco et al. · Annals of Oncology · 2021 · 62 citations · Full text

Surgical Oncology, Bone Sarcoma Group, Gastrointestinal Oncology +10

Induction of systemic serum procalcitonin and cardiocirculatory reactions after isolated limb perfusion with recombinant human tumor necrosis factor-α and melphalan

Christoph Kettelhack, P. Hohenberger, G Schulze et al. · Critical Care Medicine · 2000 · 43 citations